Conversion of calcineurin inhibitors to sirolimus in liver transplant recipients.

被引：0
|
作者：
Mies, Sergio [1 ]
Beduschi, Thiago [1 ]
Silva, Vinicius M. R. [1 ]
Mies, Ana Olga N. G. F. [1 ]
Della Guardia, Bianca [1 ]
Baia, Carlos E. S. [1 ]
de Almeida, Marcio D. [1 ]
机构：
[1] Albert Einstein Hosp, Liver Unit, Sao Paulo, Brazil
来源：
LIVER TRANSPLANTATION | 2007年 / 13卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
441
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [31] Effects of Conversion from Calcineurin Inhibitors to Sirolimus or Everolimus on Renal Function and Possible Mechanisms in Liver Transplantation Recipients
    Li, L-C
    Hsu, C-N
    Lin, C-C
    Cheng, Y-F
    Chen, D-W
    Lee, C-H
    Chen, C-L
    [J]. TRANSPLANTATION, 2017, 101 (05) : 208 - 208
  • [32] Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
    Bakhtiari, H.
    Todd, S.
    Snyder, H.
    Lo, D.
    Flynn, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 759 - 759
  • [33] PREDICTORS OF PROTEINURIA FOLLOWING SIROLIMUS CONVERSION IN LIVER TRANSPLANT RECIPIENTS
    Wadei, Hani
    Zaky, Ziad S.
    Kedveny, Andrew P.
    Mai, Martin
    Taner, Burcin
    Perry, Dana
    Rosser, Barry
    Gonwa, Thomas A.
    [J]. HEPATOLOGY, 2010, 52 (04) : 834A - 834A
  • [34] HIGH DOSES OF CALCINEURIN INHIBITORS ARE ASSOCIATED WITH LOW LEVELS OF T REGULATORY CELLS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS.
    Piard-Ruster, Karine S.
    Silva, Richard
    Berquist, William
    Pham, Betty
    Gallo, Amy
    Krams, Sheri M.
    Esquivel, Carlos O.
    Martinez, Olivia M.
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 : 57 - 57
  • [35] Conversion from calcineurin inhibitors to sirolimus improves renal function in heart transplant recipients with de novo renal dysfunction
    El-Hamamsy, I.
    Stevens, L. M.
    White, M.
    Perrault, L. P.
    Pellerin, M.
    Carrier, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S120 - S121
  • [36] The Sirolimus Era: Infections in kidney transplant recipients.
    Lattes, R
    del Carmen Rial, M
    Radisic, M
    Ryb, M
    Escudero, P
    Casadei, D
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 353 - 354
  • [37] Conversion from calcineurin inhibitors to sirolimus in transplant-associated thrombotic microangiopathy
    Kanunnikov, Mikhail M.
    Rakhmanova, Zhemal Z.
    Levkovsky, Nikita V.
    Vafina, Aliya I.
    Goloshapov, Oleg V.
    Shchegoleva, Tatiana S.
    Vlasova, Julia J.
    Paina, Olesya V.
    Morozova, Elena V.
    S. Zubarovskaya, Ludmilla
    Kulagin, Alexander D.
    S. Moiseev, Ivan
    [J]. CLINICAL TRANSPLANTATION, 2021, 35 (02)
  • [38] USE OF SIROLIMUS IN PAEDIATRIC RENAL TRANSPLANT RECIPIENTS.
    McCulloch, Mignon
    Taylor, Judy
    Walsh, Grainne
    Koffman, Geoff
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 : 109 - 109
  • [39] Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus
    Teutonico, A
    Schena, PF
    Di Paolo, S
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (10): : 3128 - 3135
  • [40] A review on the roles of mTOR inhibitors in pediatric liver transplant recipients.
    Dahti-Khavidaki, Simin
    Moghadamnia, Marjan
    Alimadadi, Hossein
    [J]. TRANSPLANTATION, 2024, 108 (09) : 699 - 699
12345